OPKO Health, Inc. (TLV:OPK)

Market Cap	3.63B
Revenue (ttm)	2.24B
Net Income (ttm)	-596.83M
Shares Out	n/a
EPS (ttm)	-0.86
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,745
Average Volume	577,728
Open	454.70
Previous Close	453.30
Day's Range	450.90 - 458.90
52-Week Range	402.00 - 734.40
Beta	1.19
RSI	51.92
Earnings Date	Jul 30, 2025

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 2,997
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: OPK

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Financial numbers in USD